NEXT Financial Group, Inc - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 49 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2016. The put-call ratio across all filers is 3.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2021$1,0000.0%2000.0%0.00%
Q2 2021$1,0000.0%2000.0%0.00%
Q1 2021$1,0000.0%2000.0%0.00%
Q4 2020$1,0000.0%2000.0%0.00%
Q3 2020$1,0002000.0%0.00%
Q1 2020$0
-100.0%
2000.0%0.00%
Q4 2019$1,0002000.0%0.00%
Q3 2019$0
-100.0%
2000.0%0.00%
Q1 2019$1,0000.0%2000.0%0.00%
Q4 2018$1,000
-50.0%
2000.0%0.00%
-100.0%
Q3 2018$2,000
+100.0%
2000.0%0.00%
Q3 2017$1,000
-99.9%
2000.0%0.00%
Q2 2017$1,000,0000.0%2000.0%0.00%
Q1 2017$1,000,0002000.0%0.00%
Q4 2016$0
-100.0%
2000.0%0.00%
Q3 2016$1,0002000.0%0.00%
Q2 2016$02000.0%0.00%
Q1 2016$02000.0%0.00%
Q4 2015$0
-100.0%
2000.0%0.00%
Q3 2015$1,0002000.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2016
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 340,000$1,459,0000.53%
RTW INVESTMENTS, LP 4,733,323$20,306,0000.31%
APIS CAPITAL ADVISORS, LLC 70,000$300,0000.29%
Hudson Bay Capital Management LP 1,800,000$7,722,0000.10%
COWEN AND COMPANY, LLC 249,215$1,069,0000.05%
Kerrisdale Advisers, LLC 100,000$429,0000.05%
Woodline Partners LP 496,172$2,129,0000.04%
Shay Capital LLC 60,000$257,0000.03%
Walleye Capital LLC 231,037$991,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 212,700$912,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders